Obesity / GLP-1 / GIP Competitive Intelligence

KOL analysis · pipeline · CI scan · KOL tracker · guidelines · May 2026

Saved

Loading…

Pipeline assets

—

FDA review

—

Phase 3 active

—

KOLs tracked

—

Guidelines

—

Click "Refresh" to generate a live KOL-grade intelligence brief

Click "Refresh analysis" to generate a live, opinionated KOL brief on the current obesity/GLP-1 landscape.

Company Stage Mechanism

Pipeline summary — key data by asset

Company	Asset	Mechanism	Indication(s)	Stage	Status	Key date	Ph3 WL%	Trial	Strategic read

Select dimensions and click "Run CI scan" to pull the latest intelligence.

Track who's shaping the narrative — publications, congress podiums, advisory board relationships

Affiliation Specialty Tier

KOL roster

Name	Institution	Specialty	Tier	Company relationships	Publications / congress	Known positions	Watch flag

Living guideline registry — GLP-1/GIP relevance · KOL committee links · change alerts

Society Domain GLP relevance Status

Guideline registry

Society	Guideline	Domain	Published	Status	GLP-1/GIP stance	Relevance	Key KOLs on panel	Commercial implication

Obesity GLP-1 GIP competitive intelligence dashboard